United Therapeutic (UTHR) Stock Price, Quote & News

Company Profile

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to d...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 301 608 9292

Website: www.unither.com

Address:

1000 Spring Street, Silver Spring, United States

JohnathanGarmon542 Aug. 4 at 2:50 PM

$UTHR

0 · Reply

JohnathanGarmon542 Aug. 4 at 2:07 PM

$UTHR

0 · Reply

JonelleWilson209 Aug. 4 at 1:15 PM

$UTHR

0 · Reply

FrancisMillner512 Aug. 4 at 12:20 PM

$UTHR 🚨 QNTM sues CIBC & RBC for $700M+ in NY court: - Alleges spoofing & market manipulation (2020–2024) - Claims fake orders tanked stock from $460 → <$25 - Legal memo includes trading logs & order flow - Top firms: Freedman Normand Friedland + Christian Attar - Contingency-based = no cost to QNTM - If motion to dismiss fails → Discovery phase begins 🔍 💥 Microcap + legal leverage + no dilution 🎯 Near-term target: $40+ 👀 Rare asymmetric upside

0 · Reply

WallStreetBuyDip Aug. 2 at 11:20 PM

same game plan for $UTHR as always, waiting on H% to be low enough for me to buy

0 · Reply

WallStreetBuyDip Aug. 2 at 10:06 PM

$UTHR Price has been ranging between $274.70 and $410.00 recently, currently trading at $294.28 with an average volume of 451,020.

0 · Reply

wahoowa96 Aug. 1 at 11:36 PM

$UTHR isn't 95% of 45M shares are held by institutions? So 4 million shares are given to the retail. 4M x $300 is about 1.2 billion dollars. .5M-1M shares left to the public in the float. Guys like me holding 30 share are long holders and trade with 10 extra shares a quarter. That's gonna leave very little number of shares to trade and the company buy back will overcome the short's efforts. I like it better than useless 7% dividend of Pfizer. Why wait in line with Transmedic for kidney donation for kidney transplant when you can do kidney xenografts?

0 · Reply

stevemano Aug. 1 at 5:14 PM

$UTHR I love the smell of shorts burning in the morning! $MNKD strong!

2 · Reply

topstockalerts Aug. 1 at 12:05 PM

$UTHR waking up ?..

0 · Reply

OpenOutcrier Aug. 1 at 11:16 AM

$UTHR (+5.6% pre) United Therapeutics announces $1 billion share repurchase program https://ooc.bz/l/72189

0 · Reply

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

Jul 30, 2025, 10:51 PM EDT - 4 days ago

United Therapeutics Corporation (UTHR) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 6:30 AM EDT - 5 days ago

United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results

Jul 16, 2025, 7:00 AM EDT - 19 days ago

United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025

Jun 24, 2025, 7:00 AM EDT - 5 weeks ago

United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver

Jun 23, 2025, 7:00 AM EDT - 6 weeks ago

United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension

Jun 11, 2025, 1:36 PM EDT - 7 weeks ago

United Therapeutics: Tanking On Rival's PAH Data - I'd Consider Buying Stock

Apr 30, 2025, 1:09 PM EDT - 3 months ago

United Therapeutics Corporation (UTHR) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 6:30 AM EDT - 3 months ago

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

Apr 21, 2025, 7:00 AM EDT - 3 months ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference

Apr 4, 2025, 7:00 AM EDT - 4 months ago

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

Mar 29, 2025, 8:17 AM EDT - 4 months ago

United Therapeutics: Don't Fear The Patent Expiration Too Much

Mar 4, 2025, 7:00 AM EST - 5 months ago

United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025

Feb 26, 2025, 2:14 PM EST - 5 months ago

United Therapeutics Corporation (UTHR) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 6:30 AM EST - 5 months ago

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 1:06 AM EST - 5 months ago

United Therapeutics: A Unique Business With High Margins And Expansion Potential

Feb 24, 2025, 7:00 AM EST - 5 months ago

United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference

Feb 19, 2025, 7:00 AM EST - 5 months ago

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025

Feb 4, 2025, 7:00 AM EST - 6 months ago

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Feb 3, 2025, 7:00 AM EST - 6 months ago

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

Jan 21, 2025, 7:00 AM EST - 6 months ago

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

Jan 6, 2025, 7:00 AM EST - 7 months ago

United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 29, 2024, 4:25 PM EST - 7 months ago

The Zen Ten - My Top Picks For 2025

AAPL BBW IBKR INTU META NVDA TSM

Dec 17, 2024, 7:00 AM EST - 8 months ago

United Therapeutics Announces Successful World's First UKidney Transplant

Nov 15, 2024, 6:27 PM EST - 9 months ago

United Therapeutics: Competitive Advantages At Such Cheap Multiples Scream Buy

Nov 15, 2024, 7:00 AM EST - 9 months ago

United Therapeutics Expands Into Organ Transplants, But Tyvaso's Legal Battles Loom

Nov 14, 2024, 5:16 PM EST - 9 months ago

United Therapeutics: One To Believe In Despite Competitive Threats

Nov 5, 2024, 4:30 PM EST - 9 months ago

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

Oct 30, 2024, 3:09 PM EDT - 9 months ago

United Therapeutics Corporation (UTHR) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 6:30 AM EDT - 9 months ago

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

Oct 23, 2024, 7:00 AM EDT - 10 months ago

United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

Oct 23, 2024, 6:30 AM EDT - 10 months ago

United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024

Sep 24, 2024, 7:00 AM EDT - 11 months ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting

Sep 10, 2024, 7:00 AM EDT - 11 months ago

United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever

Aug 30, 2024, 12:02 PM EDT - 1 year ago

United Therapeutics Shares Thrive

Aug 28, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation to Present at Upcoming Investor Conferences

Aug 19, 2024, 10:00 PM EDT - 1 year ago

United Therapeutics: Economics Support Compounding Ability

Jul 31, 2024, 11:28 AM EDT - 1 year ago

United Therapeutics Corporation (UTHR) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 6:30 AM EDT - 1 year ago

United Therapeutics Corporation Reports Second Quarter 2024 Financial Results

Jul 24, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024

Jul 10, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Jun 28, 2024, 10:36 AM EDT - 1 year ago

Big Money Elevating United Therapeutics

Jun 27, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors

Jun 5, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

May 1, 2024, 2:46 PM EDT - 1 year ago

United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript

May 1, 2024, 6:30 AM EDT - 1 year ago

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

Apr 26, 2024, 2:02 PM EDT - 1 year ago

CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplant

Apr 24, 2024, 9:00 AM EDT - 1 year ago

United Therapeutics Announces World's First Successful Xenothymokidney Transplant

Apr 24, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024

Apr 16, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference

JohnathanGarmon542 Aug. 4 at 2:50 PM

$UTHR

0 · Reply

JohnathanGarmon542 Aug. 4 at 2:07 PM

$UTHR

0 · Reply

JonelleWilson209 Aug. 4 at 1:15 PM

$UTHR

0 · Reply

FrancisMillner512 Aug. 4 at 12:20 PM

0 · Reply

WallStreetBuyDip Aug. 2 at 11:20 PM

same game plan for $UTHR as always, waiting on H% to be low enough for me to buy

0 · Reply

WallStreetBuyDip Aug. 2 at 10:06 PM

$UTHR Price has been ranging between $274.70 and $410.00 recently, currently trading at $294.28 with an average volume of 451,020.

0 · Reply

wahoowa96 Aug. 1 at 11:36 PM

0 · Reply

stevemano Aug. 1 at 5:14 PM

$UTHR I love the smell of shorts burning in the morning! $MNKD strong!

2 · Reply

topstockalerts Aug. 1 at 12:05 PM

$UTHR waking up ?..

0 · Reply

OpenOutcrier Aug. 1 at 11:16 AM

$UTHR (+5.6% pre) United Therapeutics announces $1 billion share repurchase program https://ooc.bz/l/72189

0 · Reply

JarvisFlow Jul. 31 at 3:44 PM

Wells Fargo updates rating for United Therapeutics ( $UTHR ) to Equal-Weight, target set at 314 → 295.

0 · Reply

ZacksResearch Jul. 31 at 3:40 PM

$UTHR missed on earnings — but there’s a twist 📉➡️📈 Q2 EPS came in below estimates, but revenues jumped 12% year over year thanks to strong Tyvaso and broader product sales. Full breakdown here 👉 https://www.zacks.com/stock/news/2644115/uthr-q2-earnings-miss-estimates-higher-tyvaso-sales-aid-revenues-yy?cid=sm-stocktwits-2-2644115-teaser-5067&ADID=SYND_STOCKTWITS_TWEET_2_2644115_TEASER_5067

0 · Reply

wahoowa96 Jul. 31 at 2:39 PM

$UTHR I think mRNA LP(a) gene one-time gene editing from Arcturus is something worth gambling for partnership-based development. It will definitely as good as or better than LLY/Verve's LP(a) version. But fine...wish United Therapeutics offer some dividends if it plans to stay underwater long time.

0 · Reply

ZacksResearch Jul. 31 at 2:24 PM

$UTHR drops 5.3% after mixed Q2 results 📉 What's next for this biotech player? 🧪 EPS miss at $6.41 vs. $6.80 estimate, yet earnings per share up 10% YoY 💊 Revenue beat at $798.6M, driven by revenue growth of Tyvaso & Orenitram 🔬 Key phase III programs progressing, with pivotal data expected in 2025 & 2026 See the full breakdown and future prospects here 👉 https://www.zacks.com/stock/news/2644115/uthr-q2-earnings-miss-estimates-higher-tyvaso-sales-aid-revenues-yy?cid=sm-stocktwits-2-2644115-body-5001&ADID=SYND_STOCKTWITS_TWEET_2_2644115_BODY_5001

0 · Reply

Outcomes Jul. 31 at 1:44 PM

$MNKD ....compelled to sell some and buy $UTHR @ $282

2 · Reply

JarvisFlow Jul. 31 at 11:30 AM

HC Wainwright & Co. has updated their rating for United Therapeutics ( $UTHR ) to Buy with a price target of 400.

0 · Reply

clan Jul. 31 at 9:35 AM

$MNKD $UTHR Based on what came out of yesterday's conference call, it could easily be argued that Unither, and Oppenheimer, are expecting grand results from Teton 2. That w/b good for Unither, IPF patients, Mannkind, and .... MNKD shareholders! Trial data expected out in as little as 5 weeks from now. Hold onto your hat!

0 · Reply

lukasgx Jul. 30 at 8:32 PM

$UTHR $LQDA see UTHR metrics not versus q2 24 but q1 25 and you will clearly understand why q3 2025 will start and get negative growth. Good for Lqda and thanks LQDA 😇

1 · Reply

EatingCatPoop Jul. 30 at 6:55 PM

$UTHR funs over here. Will be cut in half soon

0 · Reply

BNBComedian Jul. 30 at 5:19 PM

$UTHR dead money

0 · Reply

Rolf1968 Jul. 30 at 2:07 PM

$UTHR did she mention how Grand the Tetons are?!

0 · Reply

d_risk Jul. 30 at 12:34 PM

$UTHR - United Therapeutics Corporation Common Stock - 10Q - Updated Risk Factors UTHR’s 10-Q flags new cybersecurity risks, acquisition integration challenges, tighter financing constraints, heightened stock volatility, and increased litigation exposure tied to its Public Benefit Corporation status and Delaware-specific governance changes. #Biotechnology #LitigationExposure #StockVolatility #FinancingConstraints #AcquisitionIntegration #CybersecurityRisks 🟢 Added 🟠 Removed https://d-risk.ai/UTHR/10-Q/2025-07-30

0 · Reply

Market Cap	13.27B
Revenue (ttm)	2.88B
Net Income (ttm)	1.20B
EPS (ttm)	N/A
PE Ratio	10.72
Forward PE	10.02
Profit Margin	41.53%
Debt to Equity Ratio	0.03

Volume	909,200
Avg Vol	600,104
Day's Range	N/A - N/A
Shares Out	45.11M
Stochastic %K	62%
Beta	0.57
Analysts	Strong Sell
Price Target	$378.83